IM Cannabis Corp. engages in importation, distribution and sale of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and full-spectrum cannabis extracts under the IMC, BLKMT, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is h…
| Periodo | 2025-03 | 2024-11 | 2024-08 | 2024-05 |
|---|---|---|---|---|
| Real | $-6.60 | $-12.30 | $-6.90 | $-75.60 |
| Estimado | $-16.20 | $-28.80 | $-35.10 | $-36.00 |
| Sorpresa | +59.3% | +57.3% | +80.3% | -110.0% |
| Métrica | IMCC | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 17.7% | 57.4% | -39.7% |
| Operating Margin | -21.2% | -34.4% | +13.2% |
| Net Margin | -20.7% | -32.5% | +11.8% |
| FCF Margin | 8.6% | -12.6% | +21.2% |
| ROE | — | -39.2% | — |
| ROA | -35.7% | -30.9% | -4.7% |
| Current Ratio | 0.67 | 2.73 | -2.06 |
| Debt / Equity | -0.25 | 0.28 | -0.53 |
| Tendencia (Piotroski) | FY25 | FY24 |
|---|---|---|
| ✗Rentabilidad sobre activos positiva | -35.7% | — |
| ✓Flujo de caja operativo positivo | CA$5M | −CA$1M |
| ✗Rentabilidad sobre activos al alza | -35.7% | -27.0% |
| ✓Caja operativa/activos supera al ROA | 14.9% | ROA -35.7% |
| ✗Menos deuda a largo plazo | 2.9% | 1.2% |
| ✗Mejor liquidez (ratio corriente) | 0.67 | 0.67 |
| ✗Sin aumentar el nº de acciones | — | 2M |
| ✓Margen bruto al alza | 17.7% | 15.6% |
| ✓Rotación de activos al alza | 1.72 | 1.38 |
| Calidad del negocio | FY25 |
|---|---|
| ✗Margen FCF > 10 % | 8.6% |
| ✓ROCE > 10 % | 510.4% |
| ✗Ventas > 5 %/año (3 años) | 0.2% |
| ✓Deuda neta/EBITDA < 3x | -1.3x |
| ✗Reinversión (I+D + capex) > 3 % de ventas | 0.0% |
IM Cannabis Corp. cotiza a 1.39 USD y tiene una capitalización bursátil de $2M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud